Primary tumour response on breast MRI as a predictor of axillary pathologic response in breast cancer patients treated with neoadjuvant chemotherapy - Summary - MDSpire

Primary tumour response on breast MRI as a predictor of axillary pathologic response in breast cancer patients treated with neoadjuvant chemotherapy

  • By

  • Florien J. G. van Amstel

  • Rik G. M. van Mierlo

  • Patty J. Nelemans

  • Sanne M. E. Engelen

  • Janneke Houwers

  • Loes F. S. Kooreman

  • Vivianne C. G. Tjan-Heijnen

  • Sabine Siesling

  • Marjolein L. Smidt

  • Thiemo J. A. van Nijnatten

  • December 23, 2025

  • 0 min

Share

Objective:

To investigate if breast radiologic response on MRI can predict axillary pathologic response in breast cancer patients treated with neoadjuvant chemotherapy (NACT).

Key Findings:
  • Include specific statistical data to support the findings.
Interpretation:

Emphasize the clinical implications of using breast MRI for predicting axillary pathologic response.

Limitations:
  • Expand to include potential biases in patient selection.
Conclusion:

Reiterate the importance of findings in guiding treatment strategies.

Original Source(s)

Related Content